Finance

Lists
CNMD:NYSE
Conmed Corp
USD 46,72
-0,89%
(-0,42) 1D
USD 46,72
0,00% (0,00)
After hours
Closed: 16 Okt., 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNMD...
Open
USD 47,32
High
USD 47,80
Low
USD 46,50
Mkt. cap
1,40 mjd
Avg. vol.
365,24 k
Volume
413,97 k
P/E ratio
25,30
52-wk high
USD 53,66
52-wk low
USD 31,44
EPS
USD 1,85
Beta
0,94
Shares outstanding
29,95 m
No. of employees
4 k
Open
USD 47,32
High
USD 47,80
Low
USD 46,50
Mkt. cap
1,40 mjd
Avg. vol.
365,24 k
Volume
413,97 k
P/E ratio
25,30
52-wk high
USD 53,66
52-wk low
USD 31,44
EPS
USD 1,85
Beta
0,94
Shares outstanding
29,95 m
No. of employees
4 k
News stories
From web sources and news partners
About Conmed Corp
CEOCurt R. Hartman
Employees3,9 k
Founded1970
HeadquartersLargo, Florida, Verenigde State van Amerika
SectorMedical device
Websiteconmed.com
Analyst ratings
Based on 6 analysts giving stock ratings to CNMD in the past 3 months
Hold
Buy
0
Hold
5
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CNMD in the last 3 months.
Highest
Current USD 46,72
USD 46,00 (-1,54%)
Average
USD 45,25 (-3,15%)
Lowest
USD 45,00 (-3,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Sell
Maintained
-
-
07/30/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
USD 45,00
-3,7%
07/30/2026
Vik Chopra
BMO Capital
Hold
Maintained
USD 45,00
-3,7%
07/29/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
USD 46,00
-1,5%
07/30/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
USD 45,00
-3,7%
07/30/2026
Michael Matson
Needham
Hold
Maintained
-
-
07/30/2026
Unknown Analyst
BMO Capital
Hold
Initiated
USD 36,00
-22,9%
07/09/2026
Next call oor 12 dae
Wo. 28 Okt., 22:30
Fiscal period
Q3 2026
- / USD 1,00
Revenue / Est. (USD)
- / 336,25 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
337,93 m
373,20 m
317,05 m
343,49 m
Cost of goods sold
148,41 m
196,81 m
133,60 m
139,13 m
Cost of revenue
148,41 m
196,81 m
133,60 m
139,13 m
Research and development expenses
13,90 m
14,90 m
16,33 m
15,50 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139,00 m
134,42 m
133,48 m
138,57 m
Operating expense
152,90 m
149,31 m
149,81 m
154,07 m
Total operating expenses
301,31 m
346,13 m
283,41 m
293,20 m
Operating income
36,62 m
27,07 m
33,64 m
50,29 m
Other non operating income
-
-363,00 k
-
2,82 m
EBT including unusual items
4,27 m
29,25 m
18,36 m
31,35 m
EBT excluding unusual items
29,01 m
19,34 m
26,58 m
45,23 m
Income tax expense
1,41 m
12,51 m
4,53 m
8,28 m
Effective tax rate
33,09%
42,78%
24,66%
26,40%
Other operating expenses
-
-
-
-
Net income
2,86 m
16,74 m
13,83 m
23,07 m
Net profit margin
0,85%
4,49%
4,36%
6,72%
Earnings per share
1,08
1,43
0,89
1,38
Interest and investment income
-
-
-
-
Interest expense
-7,61 m
-7,37 m
-7,06 m
-7,88 m
Net interest expenses
-7,61 m
-7,37 m
-7,06 m
-7,88 m
Depreciation and amortization charges
-
-
-
-
EBITDA
55,23 m
44,72 m
52,47 m
69,34 m
Gain or loss from assets sale
-
-
-3,92 m
2,40 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme